unknown
Stage
About
Atisama Therapeutics develops splice-switching oligonucleotide therapies that modulate gene transcription to restore molecular balance and treat chronic inflammatory diseases.
Explore Atisama Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.